![Houman Ashrafian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Houman Ashrafian
Technik-/Wissenschafts-/F&E-Leiter bei
SANOFI
Profil
Dr. Houman Ashrafian is an Executive VP, Head-Research & Development at Sanofi, a Managing Partner at SV Health Managers LLP, a Scientific Advisor at SV Health Investors LLP and a Chairman at Weatherden Ltd. He is on the Board of Directors at Zarodex Therapeutics Ltd., Cellinta Ltd. and Cybele Therapeutics Ltd. Dr. Ashrafian was previously employed as a Co-Founder by TRex Bio, Inc., a Co-Founder by Heart Metabolics Ltd., a Founder by HMBL Ltd., a Chairman by Alchemab Therapeutics Ltd., a Co-Founder by Catamaran Bio, Inc., a Co-Founder by Dualitas Ltd., and a Chairman by Enara Bio Ltd. He also served on the board at Prilenia Therapeutics BV, TRex Bio Ltd., Ervaxx Ltd., Sitryx Therapeutics Ltd., Imbria Pharmaceuticals, Inc., Mestag Therapeutics Ltd. and Therini Bio, Inc. He received his undergraduate degree from the University of Oxford, an undergraduate degree from the University of Cambridge, a graduate degree from the University of Cambridge and a doctorate degree from the University of Oxford.
Aktive Positionen von Houman Ashrafian
| Unternehmen | Position | Beginn |
|---|---|---|
| SANOFI | Technik-/Wissenschafts-/F&E-Leiter | 11.09.2023 |
SV Health Managers LLP
 SV Health Managers LLP Investment ManagersFinance SVHM is a hands-on manager which focuses investments in the human life sciences sector (biotechnology/biopharmaceuticals, medical devices, healthcare services and healthcare information technology). Their geographic focus is on North America and Western Europe, but they consider investment opportunities in other regions where there is a well-developed life sciences sector. SVHM's invests in companies with a very high quality management team and a business model that could provide a strong increase in value, often with a key technology protectable by law. They may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market. | Portfolio Manager-Aktien | 01.01.2016 |
Weatherden Ltd.
 Weatherden Ltd. BiotechnologyHealth Technology Engages drug discovery and development | Gründer | - |
Zarodex Therapeutics Ltd.
 Zarodex Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Direktor/Vorstandsmitglied | 26.07.2017 |
Cellinta Ltd.
 Cellinta Ltd. Investment ManagersFinance Functions as an alternative investment manager for healthcare industry | Direktor/Vorstandsmitglied | 10.03.2020 |
Cybele Therapeutics Ltd.
 Cybele Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Direktor/Vorstandsmitglied | 11.12.2019 |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Private Equity Investor | 01.01.2016 |
Ehemalige bekannte Positionen von Houman Ashrafian
| Unternehmen | Position | Ende |
|---|---|---|
HMBL Ltd.
 HMBL Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development on biotechnology | Gründer | 03.06.2017 |
Trex Bio, Inc.
 Trex Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures immunotherapies for autoimmune and inflammatory diseases | Gründer | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Ausbildung von Houman Ashrafian
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
22
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 22 |
|---|---|
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SV Health Managers LLP
SV Health Managers LLP Investment ManagersFinance SVHM is a hands-on manager which focuses investments in the human life sciences sector (biotechnology/biopharmaceuticals, medical devices, healthcare services and healthcare information technology). Their geographic focus is on North America and Western Europe, but they consider investment opportunities in other regions where there is a well-developed life sciences sector. SVHM's invests in companies with a very high quality management team and a business model that could provide a strong increase in value, often with a key technology protectable by law. They may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market. | Finance |
Heart Metabolics Ltd.
 Heart Metabolics Ltd. BiotechnologyHealth Technology Develops medical therapy for the treatment of heart failure | Health Technology |
HMBL Ltd.
HMBL Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development on biotechnology | Commercial Services |
Dualitas Ltd.
 Dualitas Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in developing technologies to deliver holographic and augmented reality products and services | Commercial Services |
Weatherden Ltd.
Weatherden Ltd. BiotechnologyHealth Technology Engages drug discovery and development | Health Technology |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. BiotechnologyHealth Technology Develop disease-modifying therapeutics for autoimmune and inflammatory disease | Health Technology |
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in halt chronic neuroinflammation and neuronal damage caused by vascular injury to treat severe neurological & retinal diseases | Commercial Services |
Alchemab Therapeutics Ltd.
 Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Engages in developing of antibodies | Health Technology |
Zarodex Therapeutics Ltd.
Zarodex Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Commercial Services |
Trex Bio, Inc.
Trex Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Mestag Therapeutics Ltd.
 Mestag Therapeutics Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Cellinta Ltd.
Cellinta Ltd. Investment ManagersFinance Functions as an alternative investment manager for healthcare industry | Finance |
Cybele Therapeutics Ltd.
Cybele Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Commercial Services |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company developing allogeneic, off the shelf CAR-NK cell therapies for cancer treatment | Health Technology |
Prilenia Therapeutics BV
 Prilenia Therapeutics BV BiotechnologyHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
TRex Bio Ltd.
 TRex Bio Ltd. BiotechnologyHealth Technology Provides biotechnology research and development services | Health Technology |
Enara Bio Ltd.
 Enara Bio Ltd. BiotechnologyHealth Technology Develops cancer therapies | Health Technology |
